Carcinomatous Meningitis in Non–Small-Cell Lung Cancer: Response to High-Dose Erlotinib
- 1 August 2009
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (22), e31-e32
- https://doi.org/10.1200/jco.2008.21.0963
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung AdenocarcinomaJournal of Thoracic Oncology, 2008
- Successful Treatment of Carcinomatous Meningitis with Gefitinib in a Patient with Lung Adenocarcinoma Harboring a Mutated EGF Receptor GeneThe Tohoku Journal of Experimental Medicine, 2008
- Response and Resistance in a Non–Small-Cell Lung Cancer Patient With an Epidermal Growth Factor Receptor Mutation and Leptomeningeal Metastases Treated With High-Dose GefitinibJournal of Clinical Oncology, 2006
- Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinibInternational Journal of Clinical Oncology, 2006
- Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutationNature Clinical Practice Oncology, 2006
- Management of leptomeningeal malignancyExpert Opinion on Pharmacotherapy, 2005
- Leptomeningeal carcinomatosisCancer Treatment Reviews, 1999